1.Impact of 99Tcm-FAPI SPECT/CT on Diagnostic Efficacy and Immunotherapy Decision-Making in Advanced Colorectal Cancer
Yu ZHANG ; Zhiyi LIN ; Hong CHEN ; Mingdian YU ; Chenshen HUANG ; Wenxin CHEN
Chinese Journal of Medical Imaging 2025;33(7):768-774
Purpose To explore the diagnostic efficacy of 99Tcm labeled fibroblast activation protein inhibitor(FAPI)SPECT/CT for metastatic lesions in advanced colorectal cancer and its impact on decisions regarding immunotherapy,and to compare it with 18F-FDG PET/CT.Materials and Methods A total of 34 patients with advanced colorectal cancer who underwent both 99Tcm-FAPI SPECT/CT and 18F-FDG PET/CT imaging from August 2022 to November 2023 in Fuzhou University Affiliated Provincial Hospital were prospectively included.The gold standard was based on biopsy or clinical and imaging follow-up results.Chi-square tests and rank sum tests were used to compare differences between the groups.Results Among the 34 patients,17 patients subsequently received immunotherapy.The uptake of 99Tcm-FAPI was significantly higher than that of 18F-FDG for the primary tumor site(Z=-2.389,P=0.017),peritoneal metastasis(Z=-2.497,P=0.013)and liver metastasis(Z=-0.106,P=0.015).The diagnostic efficacy of 99Tcm-FAPI SPECT/CT for patients with peritoneal metastasis was superior to that of 18F-FDG PET/CT(χ2=4.65,P=0.033).Metastatic lesions that did not uptake 99Tcm-FAPI had a better clinical prognosis after immunotherapy(χ2=11.839,P=0.006),and maximum standardized uptake value(SUVmax)-FDG/SUVmax-FAPI ratio was a promising predictive factor for a better prognosis after immunotherapy,with an optimal cut-off value of 5.04.Conclusion 99Tcm-FAPI SPECT/CT has superior diagnostic efficacy for peritoneal metastasis in advanced colorectal cancer compared with 18F-FDG PET/CT.SUVmax-FDG/SUVmax-FAPI ratio is a promising radiomic parameter for predicting patient prognosis after immunotherapy,which can help guide clinical decision-making further.
2.Impact of 99Tcm-FAPI SPECT/CT on Diagnostic Efficacy and Immunotherapy Decision-Making in Advanced Colorectal Cancer
Yu ZHANG ; Zhiyi LIN ; Hong CHEN ; Mingdian YU ; Chenshen HUANG ; Wenxin CHEN
Chinese Journal of Medical Imaging 2025;33(7):768-774
Purpose To explore the diagnostic efficacy of 99Tcm labeled fibroblast activation protein inhibitor(FAPI)SPECT/CT for metastatic lesions in advanced colorectal cancer and its impact on decisions regarding immunotherapy,and to compare it with 18F-FDG PET/CT.Materials and Methods A total of 34 patients with advanced colorectal cancer who underwent both 99Tcm-FAPI SPECT/CT and 18F-FDG PET/CT imaging from August 2022 to November 2023 in Fuzhou University Affiliated Provincial Hospital were prospectively included.The gold standard was based on biopsy or clinical and imaging follow-up results.Chi-square tests and rank sum tests were used to compare differences between the groups.Results Among the 34 patients,17 patients subsequently received immunotherapy.The uptake of 99Tcm-FAPI was significantly higher than that of 18F-FDG for the primary tumor site(Z=-2.389,P=0.017),peritoneal metastasis(Z=-2.497,P=0.013)and liver metastasis(Z=-0.106,P=0.015).The diagnostic efficacy of 99Tcm-FAPI SPECT/CT for patients with peritoneal metastasis was superior to that of 18F-FDG PET/CT(χ2=4.65,P=0.033).Metastatic lesions that did not uptake 99Tcm-FAPI had a better clinical prognosis after immunotherapy(χ2=11.839,P=0.006),and maximum standardized uptake value(SUVmax)-FDG/SUVmax-FAPI ratio was a promising predictive factor for a better prognosis after immunotherapy,with an optimal cut-off value of 5.04.Conclusion 99Tcm-FAPI SPECT/CT has superior diagnostic efficacy for peritoneal metastasis in advanced colorectal cancer compared with 18F-FDG PET/CT.SUVmax-FDG/SUVmax-FAPI ratio is a promising radiomic parameter for predicting patient prognosis after immunotherapy,which can help guide clinical decision-making further.
3.Long term result of simple closure operation for perforated peptic ulcer
Zhizhan NI ; Song WANG ; Liacheng ZHU ; Chenshen HUANG ; Bunjun GE ; Qi HUANG
Chinese Journal of General Surgery 2021;36(1):47-49
Objective:To investigate the incidence of severe complications in patients with peptic ulcer perforation after simple closure operation.Methods:All discharged 117 patients after perforated peptic ulcer simple closure from Jan 2010 to June 2014 were followed-up. Focusing on patients compliance to undergo endoscopic examination and radical HP treatment within 3 months after operation, whether giving up bad habit such as smoking or drinking, whether using nonsteroidal anti-inflammatory drugs.Persisting ulcer symptoms and other complications such as reperforation, bleeding, obstruction, etc were recorded.Results:Gastroscopy was performed in 22 cases (21.4%) within 3 months after operation, and only 5 cases received HP radical treatment. There were altogether 10 cases of severe complications developed during the period of followed-up, including 6 cases of pyloric obstruction , 4 cases of reperforation, and 2 cases repeated ulcer bleeding . The average interval from perforation operation to the first serious complication was (24.8±5)months. Among them, 2 cases of perforation and 1 case of repeated obstruction were treated surgically, the rest underwent conservative treatment. Compared with the severe complications group much less patients receving early postoperative gastroscopy have had such severe complications (23.7% vs.0, P=0.184). Conclusion:After simple closure of upper gastrointestinal ulcer perforation, the low compliance rate of endoscopy and active medical treatment lead to high incidence of long-term serious complications.

Result Analysis
Print
Save
E-mail